BIOTRONIK and CardioFocus Partner to Expand Centauri™ PFA System Across 17 European Countries

BIOTRONIK, a global leader in cardiac rhythm management and electrophysiology, has entered into a strategic distribution agreement with CardioFocus. BIOTRONIK will serve as the exclusive distributor of CardioFocus’ Centauri™ Pulsed Field Ablation (PFA) System across 17 European markets, significantly broadening access to this next-generation focal ablation technology for atrial fibrillation (AF).

The Centauri™ System is CE-marked and has been used to treat over 8,000 patients in Europe. Clinical experience reported in over 40 publications has demonstrated a high level of procedural efficiency, durable cardiac lesions, and a low rate of complications.

This collaboration is a significant milestone in the commercial expansion of the Centauri™ System, a next-generation focal PFA system that provides physicians with a highly controllable, versatile solution for cardiac ablation in the treatment of paroxysmal atrial fibrillation. The Centauri system stands out due to its compatibility with widely used mapping systems and flexible workflow integration. It also has an unmatched body of real-world evidence. These features position Centauri™ as a frontrunner in the field of focal PFA.

“We are proud to collaborate with CardioFocus to expand the reach of the Centauri™ System in key European markets,” said Dr. Andreas Hecker, president of CRM/EP at BIOTRONIK. “As pulsed field ablation evolves, hospitals need solutions that combine strong clinical performance with flexibility. This collaboration reflects our ongoing commitment to advancing innovation in electrophysiology and supporting physicians in improving patient outcomes.”

“We are thrilled to partner with a well-established, clinically trusted company like BIOTRONIK to bring our technology to more physicians and patients across Europe,” said Steve Ogilvie, CardioFocus’s CEO. “BIOTRONIK’s extensive electrophysiology expertise, global presence, and dedication to physician training make them the perfect partner to promote the next stage of Centauri’s growth.”